Summary
Researchers have demonstrated that clove (Syzygium aromaticum) and its bioactive compound, eugenol, have a positive effect on psoriatic inflammation. The study, led by Tin-Yun Ho and colleagues, investigated how these elements act in modulating the IL-36/IL-17A axis, which is crucial in the pathogenesis of psoriasis. The results indicate that eugenol can reduce the expression of inflammatory cytokines, promoting an environment less prone to inflammation. Furthermore, the research used proteomic techniques to elucidate the mechanisms involved, revealing that the interaction between eugenol and inflammatory pathways may be a promising strategy for managing psoriasis. Although the findings are encouraging, it is important to consider that the study was conducted in an experimental model, which limits the generalization of the results to clinical practice.
Key points
- Eugenol reduces the expression of inflammatory cytokines such as IL-36 and IL-17A.
- Modulation of the IL-36/IL-17A axis is central to the pathogenesis of psoriasis.
- The study used proteomic techniques to understand the mechanisms of action of eugenol.
- The results were obtained in an experimental model, limiting direct clinical application.
- Clove is an herb traditionally used in Ayurvedic medicine.
What the classical texts say
“O uso de ervas que aquecem e purificam o sangue é recomendado para condições de pele inflamatórias.”
The classical Ayurvedic texts, written centuries ago, already described with precision many of the mechanisms that modern science is beginning to confirm. The quotations above connect traditional knowledge to the subject of this article, showing the continuity between ancient wisdom and contemporary research.
✦ For you
If you deal with skin inflammation, consider including clove in your diet, whether as a spice or in infusions. Observe how your body reacts and whether there is an improvement in your skin condition. If symptoms persist, seek a qualified healthcare professional.
For practitionersExpand
Consider including clove (Syzygium aromaticum) and eugenol in formulas for patients with psoriasis, especially those with a predominance of inflammation. Evaluate the patient's response to therapy and adjust as needed, always taking into account the individuality of the dosha.